Ami Organics Limited

Incorporated in 2004, Gujarat-based Ami Organics is a research and development (R&D) driven specialty chemicals manufacturer. The company focuses on developing and manufacturing advanced pharmaceutical intermediates for generic active pharmaceutical ingredients (APIs) and new chemical entities (NCEs). It also makes key starting material for agrochemical and fine chemicals.

It has developed and commercialised more than 450 pharma intermediates for APIs and NCEs, with a strong focus on select high-growth and margin therapeutic areas such as anti-retroviral, anti-inflammatory, antipsychotic, anti-cancer, anti-Parkinsons, antidepressant and anti-coagulant.

Besides having a presence in the domestic market, the company also supplies to various multinationals that cater to markets in Europe, China, Japan, Israel, UK, Latin America and the US. The company derives around half of its revenue from exports.

Over the last three years, the company has posted strong financial performance. The revenue from operations and net profit have grown at a CAGR of 19.5% and 52.2%, respectively.

The offer for sale comprises 6,059,600 equity shares. The fresh issue is of ₹200 crore, which will be used for repayment of financial facilities, working capital requirement and general corporate purposes.